The results showed that PB BAL offered deeper alveolar sampling while avoiding contamination from the larger airways. It also revealed incremental changes in the small airways and alveoli, aiding in ...

In addition to reduced RBC transfusion requirements, hemolysis markers significantly improved with the combined therapy. Results from a phase 2 clinical trial evaluating the use of dose-escalated ...

Eculizumab was started between 35 and 61 days following the onset of the NMOSD attack and partially reduced the symptoms of all 5 patients. Eculizumab treatment may reduce the symptoms of ...

A patient with PLA2R-positive membranous nephropathy later developed IgG4-related autoimmune pancreatitis and renal masses, which resolved with glucocorticoid therapy. Glucocorticoid therapy ...

The results correct a misconception in the ACR/EULAR criteria for IgG4-RD that list hypocomplementemia as a feature limited to patients with renal involvement. A new study has found that ...

Differentiating POEMS syndrome from chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is important because both have similar demyelinating features but require different treatments.

Are the out-of-pocket costs of your medications taking a toll on your finances? Rising drug costs are happening to many people with neurological diseases, but people with multiple sclerosis (MS) ...

Early diagnosis is vital in AAV with interstitial lung disease so that treatment can begin as soon as possible. Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) ...

Now that I’m in my 30s, navigating life with a progressive muscle disease like limb-girdle muscular dystrophy (LGMD) has been emotionally and mentally challenging. The fear of losing close family, or ...

Aggressive therapy is recommended in patients with high-risk PAH to secure better long-term outcomes. Significant discrepancies remain between treatment recommendations in pulmonary arterial ...

Leukocytosis, thrombocytopenia, low serum albumin, and the presence of a mutation involving the SRSF2 or TP53 genes were independent predictors of worse overall survival in patients with myelofibrosis ...

JAK inhibitor therapy at the start of conditioning led to significantly higher early B-cell recovery and significantly increased late recovery of gamma-delta T cells and natural killer cells in ...